STRATA Skin Sciences Management
Management criteria checks 2/4
STRATA Skin Sciences' CEO is Dolev Rafaeli, appointed in Oct 2023, has a tenure of 1.25 years. total yearly compensation is $986.12K, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 3.43% of the company’s shares, worth $412.29K. The average tenure of the management team and the board of directors is 2 years and 6.7 years respectively.
Key information
Dolev Rafaeli
Chief executive officer
US$986.1k
Total compensation
CEO salary percentage | 6.8% |
CEO tenure | 1.3yrs |
CEO ownership | 3.4% |
Management average tenure | 2yrs |
Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%
Aug 18Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?
Aug 07STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business
Jun 07Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?
Mar 19STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Dec 31Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?
Nov 03We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt
Jul 04STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company
Apr 18Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?
Jan 14STRATA Skin Sciences GAAP EPS of -$0.05 in-line, revenue of $9.1M beats by $0.96M
Aug 10Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment
Jul 25What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Mar 09Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years
Nov 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$9m |
Jun 30 2024 | n/a | n/a | -US$8m |
Mar 31 2024 | n/a | n/a | -US$11m |
Dec 31 2023 | US$986k | US$67k | -US$11m |
Sep 30 2023 | n/a | n/a | -US$7m |
Jun 30 2023 | n/a | n/a | -US$7m |
Mar 31 2023 | n/a | n/a | -US$6m |
Dec 31 2022 | n/a | n/a | -US$6m |
Sep 30 2022 | n/a | n/a | -US$6m |
Jun 30 2022 | n/a | n/a | -US$6m |
Mar 31 2022 | n/a | n/a | -US$3m |
Dec 31 2021 | US$283k | US$271k | -US$3m |
Sep 30 2021 | n/a | n/a | -US$2m |
Jun 30 2021 | n/a | n/a | -US$3m |
Mar 31 2021 | n/a | n/a | -US$6m |
Dec 31 2020 | US$593k | US$412k | -US$4m |
Sep 30 2020 | n/a | n/a | -US$4m |
Jun 30 2020 | n/a | n/a | -US$4m |
Mar 31 2020 | n/a | n/a | -US$3m |
Dec 31 2019 | US$1m | US$400k | -US$4m |
Sep 30 2019 | n/a | n/a | -US$3m |
Jun 30 2019 | n/a | n/a | -US$3m |
Mar 31 2019 | n/a | n/a | -US$3m |
Dec 31 2018 | US$3m | US$289k | -US$4m |
Compensation vs Market: Dolev's total compensation ($USD986.12K) is above average for companies of similar size in the US market ($USD645.26K).
Compensation vs Earnings: Dolev's compensation has increased whilst the company is unprofitable.
CEO
Dolev Rafaeli (60 yo)
1.3yrs
Tenure
US$986,121
Compensation
Dr. Dolev Rafaeli, Ph D., serves as Vice-Chairman, President and Chief Executive Officer at STRATA Skin Sciences, Inc. since October 30, 2023. He served as Chief Executive Officer, President and Director o...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 1.3yrs | US$986.12k | 3.43% $ 412.3k | |
Chief Operating Officer | 2.8yrs | US$683.79k | 1.12% $ 134.6k | |
Principal Financial Officer & Principal Accounting Officer | less than a year | no data | no data | |
General Counsel & Corporate Secretary | no data | no data | no data | |
Independent Consultant | 8.2yrs | US$732.90k | no data |
2.0yrs
Average Tenure
65.5yo
Average Age
Experienced Management: SSKN's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 1.3yrs | US$986.12k | 3.43% $ 412.3k | |
Director Emeritus | 14.8yrs | US$28.62k | no data | |
Independent Chairman | 6.7yrs | US$80.00k | no data | |
Member of Scientific Advisory Board | 7.7yrs | US$10.25k | no data | |
Independent Director | 1.3yrs | US$13.87k | no data | |
Director | no data | US$48.33k | no data | |
Independent Director | 6.7yrs | US$87.20k | 0.44% $ 52.8k |
6.7yrs
Average Tenure
60yo
Average Age
Experienced Board: SSKN's board of directors are considered experienced (6.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/22 23:54 |
End of Day Share Price | 2025/01/22 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
STRATA Skin Sciences, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gregory Chodaczek | Boenning & Scattergood, Inc. |
Jose Teodorico De Jesus Haresco | Brean Capital |
null null | CG Capital |